Renaissance Technologies’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Renaissance Technologies’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-55,400	Closed	-$2.15M	–	3535
2015 Q1	$2.15M	Sell	55,400 -63,800	-54%	-$2.46M	﹤0.01%	1897
2014 Q4	$4.01M	Sell	119,200 -116,100	-49%	-$4.1M	0.01%	1403
2014 Q3	$8.24M	Buy	235,300 +107,800	+85%	+$3.7M	0.02%	883
2014 Q2	$4.19M	Buy	127,500 +14,699	+13%	+$503K	0.01%	1331
2014 Q1	$4.16M	Sell	112,801 -38,199	-25%	-$1.4M	0.01%	1361
2013 Q4	$5.79M	Buy	151,000 +55,900	+59%	+$1.76M	0.01%	1105
2013 Q3	$2.61M	Buy	95,100 +65,700	+223%	+$1.56M	0.01%	1530
2013 Q2	$617K	Buy	+29,400	New	+$574K	﹤0.01%	2158

Other funds holding WX

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CGI

Comgest Global Investors Paris, France $4.59B AUM 12.96% 1-Year Est. Return

ACM

Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return

Renaissance Technologies's WX Position: Q2 2015 in Review

Renaissance Technologies sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q2 2015, closing a stake of 55,400 shares — an estimated $2.15M sold.

Renaissance Technologies first reported a position in WX in Q2 2013 and held it in 8 quarters. The position peaked at $8.24M in Q3 2014. 154 funds tracked by Wall St. Rank hold WX as of Q2 2015.

Renaissance Technologies reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q2 2015 after selling out during the quarter.
Renaissance Technologies sold 55,400 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q2 2015, an estimated $2.15M.
Renaissance Technologies first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2013 and held it in 8 quarters.
Renaissance Technologies's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $8.24M in Q3 2014.
154 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q2 2015.

Based on Renaissance Technologies's 13F filing for Q2 2015, filed 14 Aug 2015.